Skip to main content
. 2025 Jun 12;111(9):6162–6171. doi: 10.1097/JS9.0000000000002714

Table 4.

Characteristics classified by pathological complete response

Pathological complete response P-value
No (<100%) Yes (100%)
n = 24 n = 7
RECIST
 CR 0(0%) 7(100%) P<0.001
 PR 16(66.7%) 0(0%)
 SD 8(33.3%) 0(0%)
 PD 0(%) 0(0%)
Age
 ≥65 8(33.3%) 1(14.3%) 0.639
 <65 16(66.7%) 6(85.7%)
Sex
 Male 18(75%) 5(71.4%) 1
 Female 6(25%) 2(28.6%)
Smoking status
 Current or former smoker 14(58.3%) 2(28.6%) 0.22
 Never smoked 10(41.7%) 5(71.4%)
ECOG Physical Score
 0 15(62.5%) 3(42.9%) 0.413
 1 9(37.5%) 4(57.1%)
Preoperative nodal stage
 N1 17(70.8%) 4(57.1%) 0.652
 N2 7(29.2%) 3(42.9%)
Downstaging of nodal status in patients with N2 or N1 at baseline
 N2 to N2 or N1 to N1 15(62.5%) 0(0%) 0.007
 N2 to N1/N0 or N1 to N0 9(37.5%) 7(100%)
Stage at presentation
 IIA 10(41.6%) 2(28.6%) 0.757
 IIB 7(29.2%) 2(28.6%)
 IIIA 7(29.2%) 3(42.8%)
PD-L1 expression
 >1% 10(41.6%) 6(85.8%) 0.083
 ≤1% 14(58.4%) 1(14.2%)
TMB (Tumor mutational burden)
 >5.7 9(37.5%) 6(85.8%) 0.037
 ≤5.7 15(62.5%) 1(14.2%)